Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Buildings (2016 - 2023)

China Pharma Holdings' Buildings history spans 13 years, with the latest figure at $9.1 million for Q2 2023.

  • For Q2 2023, Buildings fell 7.12% year-over-year to $9.1 million; the TTM value through Jun 2023 reached $9.1 million, down 7.12%, while the annual FY2022 figure was $9.4 million, 8.46% down from the prior year.
  • Buildings reached $9.1 million in Q2 2023 per CPHI's latest filing, down from $9.5 million in the prior quarter.
  • In the past five years, Buildings ranged from a high of $10.3 million in Q1 2022 to a low of $9.1 million in Q2 2023.
  • Average Buildings over 5 years is $9.7 million, with a median of $9.6 million recorded in 2020.
  • Peak YoY movement for Buildings: increased 9.59% in 2021, then dropped 8.65% in 2022.
  • A 5-year view of Buildings shows it stood at $9.4 million in 2019, then increased by 6.92% to $10.0 million in 2020, then rose by 2.34% to $10.3 million in 2021, then fell by 8.46% to $9.4 million in 2022, then decreased by 3.61% to $9.1 million in 2023.
  • Per Business Quant, the three most recent readings for CPHI's Buildings are $9.1 million (Q2 2023), $9.5 million (Q1 2023), and $9.4 million (Q4 2022).